ALS Care Locator

Our ALS Care Locator can help patients find healthcare providers and infusion centers.

Find Treatment Providers

This search tool can help patients locate healthcare providers (HCPs) and infusion centers that treat ALS. The ALS Care Locator may help them find neurologists and other HCPs, some of whom have submitted at least one Benefit Investigation and Enrollment Form to Mitsubishi Tanabe Pharma America, Inc. through Searchlight Support® for RADICAVA® (edaravone). The tool includes centers which include, among others, ALS Association (ALSA) clinics, Muscular Dystrophy Association (MDA) centers, and the Les Turner ALS Center at the Northwestern University Feinberg School of Medicine. They may also search for infusion service providers who have experience administering RADICAVA®. There are various types of infusion service providers. Click on the "+" below to see a description of each.a

To start, select the type of ALS care provider you're looking for. Then enter your location information and tap or click SEARCH.

aConsult your insurance provider/coverage to determine where you are eligible to receive RADICAVA® infusions.

Healthcare Provider
Infusion Services
ALS Clinics
Healthcare Provider
Infusion Services
ALS Clinics

The ALS Care Locator is a directory with a number of functions, including a directory of infusion centers that treat ALS and which have opted-in to participate in the directory. This submission information is updated on a monthly basis.

Infusion centers listed in the directory are not affiliated with Mitsubishi Tanabe Pharma America, Inc. and do not pay to be on the list. No fees or remuneration of any kind have been or will be exchanged for participation in the ALS Care Locator. Inclusion of an infusion center in the ALS Care Locator does not constitute a referral, recommendation, endorsement, or verification of credentials, qualifications, or abilities of the infusion center listed. Similarly, the absence of an infusion center's name and information should not be construed as a negative comment from Mitsubishi Tanabe Pharma America, Inc. about the infusion center's credentials, qualifications, or abilities.

Mitsubishi Tanabe Pharma America, Inc., as well as its employees or agents, shall not be held liable for any damages or harm resulting from any use or reliance on information contained in the ALS Care Locator, and may modify, amend, remove, or cancel the ALS Care Locator at any time without notice.

If you are an HCP who treats ALS, including a neurologist and those at a multidisciplinary center, and would like to be added to the ALS Care Locator, please contact, or if you would like to be removed from the ALS Care Locator, please contact

If you are an infusion service provider who has experience administering RADICAVA® and would like to be added to the ALS Care Locator, or if you are listed in the ALS Care Locator and would like to be removed, please contact Searchlight Support® at 1-844-772-4548.


Important Safety Information

Hypersensitivity Reactions

Radicava® (edaravone) is contraindicated in patients with a history of hypersensitivity to edaravone or any of the inactive ingredients in Radicava®. Hypersensitivity reactions (redness, wheals, and erythema multiforme) and cases of anaphylaxis (urticaria, decreased blood pressure, and dyspnea) have been reported. Patients should be monitored carefully for hypersensitivity reactions, and if they occur, discontinue Radicava®, treat per standard of care, and monitor until the condition resolves.

Sulfite Allergic Reactions

Radicava® contains sodium bisulfite, and may cause allergic type reactions, including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown, but occurs more frequently in asthmatic people.

Most Common Adverse Reactions

Most common adverse reactions (at least 10% and greater than placebo) are contusion, gait disturbance, and headache.


Based on animal data, Radicava® may cause fetal harm.

Geriatric Use

No overall differences in safety or effectiveness were observed between patients 65 years of age and older and younger patients, but greater sensitivity of some older individuals cannot be ruled out.

To report suspected adverse reactions or product complaints, contact Mitsubishi Tanabe Pharma America, Inc., at 1-888-292-0058. You may also report suspected adverse reactions to the FDA at 1-800-FDA-1088 or


Radicava® is indicated for the treatment of amyotrophic lateral sclerosis (ALS).

Please see full Prescribing Information.

For more information about RADICAVA®, call 1-888-292-0058.